Cancer Diagnoses Plummeted During First Year of Pandemic
New diagnoses of eight common types of cancer significantly declined during most of the first 13 months of the pandemic.
Read More
Search Results for: prostate cancer
Alverno Laboratories to Deploy Ibex’s AI Solution for Cancer Diagnostics
Alverno Laboratories and Ibex Medical Analytics have announced a deal to deploy Ibex’s AI-powered Galen platform.
Read More
Post-COVID Cancer Screenings Up but Racial Divide Remains
Cancer screening tests rebounded in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic.
Read More
Indica Labs, Ibex Partner on AI Clinical Workflows to Improve Cancer Diagnosis
Indica Labs and Ibex Medical Analytics announced an agreement to integrate the Galen AI-based cancer diagnostics platform into the HALO AP digital pathology workflow platform.
Read More
JAMA Study: Covid-19 Had Significant Consequences for Cancer Screening
Because of the covid-19 pandemic, nearly 10 million patients weren’t screened for cancer, including breast, colorectal, and prostate.
Read More